Cartesian Therapeutics, Inc.

RNACNASDAQHealthcare● Active

$5.86

+$0.02(+0.34%)

Market Cap$172175590

P/E Ratio—

52W High$15.57

52W Low$5.6

Avg Volume217K

Open$6.00

Beta0.78

Employees Ownership Insider Trades

Cartesian Therapeutics, Inc. (RNAC) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · RNAC · as of Mar 9, 2026

Latest filing snapshot

+9+13.64%vs prior year

Cartesian Therapeutics, Inc. (RNAC) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+13.64%

Revenue / Employee

$37.3K

Net Income / Employee

$-1.74M

Market Cap

$172M

RNAC Employee Count

2024 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)	SEC filing link
2026-03-09	2025-12-31	75	+9	+13.64%
2025-03-13	2024-12-31	66	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Cartesian Therapeutics, Inc.YOU

75$172M #4

EPRX

Eupraxia Pharmaceuticals Inc.

33$201M #5

FENC

Fennec Pharmaceuticals Inc.

32$254M #6

AVTX

Avalo Therapeutics, Inc.

23$144M #7

AARD

Aardvark Therapeutics, Inc. Common Stock

22$78M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · RNAC peer comparison

About RNAC employees

RNAC Employees · Headcount

Cartesian Therapeutics, Inc. (RNAC) employee data is sourced from the annual SEC 10-K filing. As of 2025, Cartesian Therapeutics, Inc. had 75 full-time employees globally. Full-time employees only. Global consolidated headcount.

Cartesian Therapeutics, Inc. employs 75 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $37,293, reflecting the company's operational efficiency.

Cartesian Therapeutics, Inc.'s workforce increased by 9 (13.64%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Cartesian Therapeutics, Inc.'s revenue per employee of $37,293 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

RNAC Employees · 5 questions

As of the latest SEC 10-K filing (2025), Cartesian Therapeutics, Inc. had 75 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Cartesian Therapeutics, Inc. employee counthow many employees does Cartesian Therapeutics, Inc. haveRNAC total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-09